Blood Test May Predict Future Cognitive Decline in Preclinical AD Blood Test May Predict Future Cognitive Decline in Preclinical AD

Plasma p-tau217 can help identify amyloid-beta –positive individuals with preclinical Alzheimer ' s disease who are most likely to deteriorate in the coming years, new research suggests.Medscape Medical News
Source: Medscape Pathology Headlines - Category: Pathology Tags: Neurology & Neurosurgery News Source Type: news